Filing metadata

Accession number
0000905148-25-002177
Form type
Form 4
Filer
Acrivon Therapeutics, Inc.
CIK
CIK 1781174
Filed
Jun 17, 2025
Reporting period
Jun 13, 2025
Description
Insider transaction

Explore SEC Filings Hub